Two GSK Skin Cancer Drugs Approved By FDA
Two new GlaxoSmithKline (GSK) drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), have been approved for the treatment of patients with advanced
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓